Search results
Noninvasive Brain Stimulation Shows Rapid Relief for MDD
Medscape· 4 days agoAn RCT suggests transcranial alternating current stimulation may be an effective treatment for major...
Bloating in IBS-C: Can Plecanatide Help Patients?
Medscape· 7 days agoPatients with IBS-C and moderate to severe bloating achieved reductions in bloating after receiving plecanatide, but those with mild bloating showed no...
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
Morningstar· 4 days agoAmgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International Conference taking place May 12-22 in San Diego. "We look ...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 4 days agoOne researcher, Annabel Niessen of Utrecht University, discussed the results of a post-hoc analysis...
AMO Pharma to conduct Phase III trial of DM1 treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoHowever, the study's primary and secondary outcomes, based on clinician-administered subjective...
Intervention Mostly Flops for Health Workers' Well-Being During the Pandemic
MedPage Today· 5 days agoIn an intention-to-treat analysis of over 2,000 healthcare workers from 28 hospitals and federally...
Annovis tumbles as Alzheimer's treatment misses in mid-stage study
Reuters via Yahoo News· 6 days agoThe trial tested the drug buntanetap in patients with mild-to-moderate Alzheimer's disease (AD) along two scales assessing cognition and cognitive dysfunction. In a press release, the company ...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript May 2, 2024 Aurinia...
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled...
WFRV 5 Green Bay· 2 days agoHanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Phase III VELOS-3 study. Tanfanercept demonstrated ...
EYLEA HD shows promise in long-term clinical trials By Investing.com
Investing.com· 6 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ: REGN) today revealed positive long-term...